Market research studies are crucial for life sciences companies seeking to successfully develop and commercialize a pharmaceutical drug or medical device. Feedback from healthcare providers and professionals (HCPs), other medical personnel, and patients is instrumental in identifying and addressing potential market challenges prior to launch – ultimately improving outcomes for both patients and prescribers.
The insights that HCPs and Non-HCPs provide are invaluable and compensating them appropriately for their knowledge and time is essential. However, determining competitive and compliant compensation rates for market research, especially in blinded studies, can present several challenges. Below, we explore effective strategies for fair and compliant compensation for market research activities.
Compensating Based on Time
In traditional consulting and honoraria agreements, life science companies estimate the duration of an engagement and apply an hourly rate of compensation. For HCPs, hourly rates are determined based on their specialty, experience, and level of influence within the medical field. This same principle can be applied to non-blinded market research surveys.
- If a survey is expected to take one hour to complete, then participants should be compensated for one hour of work.
- For shorter surveys, the hourly rate is divided based on the time required. For example, a 15-minute survey would warrant 25% of the hourly rate.
Because the time to complete a survey may vary by respondent, increments are often used to standardize compensation. For instance, if a task takes between 15-30 minutes, the participant may be compensated for 30 minutes of work, even if they complete it in 22 minutes.
Blinded Market Research Compensation
Blinded market research studies, where participant identities are concealed, present unique compensation challenges. In these studies, the ability to differentiate participants by their experience and influence is lost, making it difficult to tailor compensation rates appropriately.
While no universal standard exists, Cutting Edge Information has observed that compensation rates for blinded participants often reflect the market rates for less influential or less experienced HCPs – those at lower tiers. These lower tier rates frequently serve as the baseline for blinded market research remuneration.
A balanced approach is essential to avoid overpaying less experienced HCPs while remaining competitive for higher-tier professionals. In a four-tier system with tier 1 at the top, one solution sets compensation ranges between higher tier 3 and lower tier 2 rates, ensuring a fair balance across all participants.
An alternative approach involves picking a single rate rather than a range, which simplifies the engagement fee. Again, the rate is often drawn from tier 2 or tier 3.
When using Cutting Edge Information rate tables, you can further customize your selection by using the full range of percentiles provided for each tier, which detail defensible base hourly rates for blinded HCP and Non-HCP participants.
Non-HCP Market Research Compensation
Compensating non-HCPs in market research follows a similar principle: participants are paid for their time based on their expertise and level of influence. The concept of benchmarking payments based on less influential participants also applies to non-HCP blinded market research. In fact, determining compensation may be more straightforward, as this audience typically consists of a more homogenous group, such as patients or specific medical technicians. As a result, the risk of over- or underpaying participants is reduced.
Conclusion
Determining appropriate compensation for market research participants, whether HCPs or Non-HCPs, is essential to ensuring fair market value for their time and expertise. By applying time-based compensation models, tailoring remuneration to expertise levels, and finding balanced solutions for blinded research, companies can foster more meaningful participation and gather higher-quality insights. Competitive, compliant compensation practices make market research both a rewarding experience for participants and an essential resource for life science companies striving for clinical and commercial success.